KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Revenue (2016 - 2026)

Medtronic's Revenue history spans 13 years, with the latest figure at $9.0 billion for Q1 2026.

  • For Q1 2026, Revenue rose 8.74% year-over-year to $9.0 billion; the TTM value through Jan 2026 reached $35.5 billion, up 6.88%, while the annual FY2025 figure was $33.5 billion, 3.62% up from the prior year.
  • Revenue for Q1 2026 was $9.0 billion at Medtronic, up from $9.0 billion in the prior quarter.
  • Across five years, Revenue topped out at $9.0 billion in Q1 2026 and bottomed at $7.4 billion in Q3 2022.
  • The 5-year median for Revenue is $8.1 billion (2022), against an average of $8.2 billion.
  • The largest annual shift saw Revenue decreased 7.71% in 2022 before it grew 8.74% in 2026.
  • A 5-year view of Revenue shows it stood at $7.6 billion in 2022, then increased by 5.27% to $8.0 billion in 2023, then rose by 5.25% to $8.4 billion in 2024, then grew by 6.64% to $9.0 billion in 2025, then grew by 0.62% to $9.0 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Revenue are $9.0 billion (Q1 2026), $9.0 billion (Q4 2025), and $8.6 billion (Q3 2025).